Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality

NCT02811198 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT02811198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02811198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
January 30, 2025
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, suicidal ideation, suicide